{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T01:25:43Z","timestamp":1786757143225,"version":"build-2736575974"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s10787-022-00993-1","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T08:04:31Z","timestamp":1651219471000},"page":"799-809","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["A raising dawn of pentoxifylline in management of inflammatory disorders in Covid-19"],"prefix":"10.1007","volume":"30","author":[{"given":"Gomaa","family":"Mostafa-Hedeab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayder M.","family":"Al-kuraishy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali I.","family":"Al-Gareeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Jeandet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9555-7300","authenticated-orcid":false,"given":"Hebatallah M.","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaber El-Saber","family":"Batiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,29]]},"reference":[{"key":"993_CR1","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S1043-6618(03)00002-1","volume":"47","author":"OM Abdel-Salam","year":"2003","unstructured":"Abdel-Salam OM, Baiuomy AR, El-Shenawy SM, Arbid MS (2003) The anti-inflammatory effects of the phosphodiesterase inhibitor pentoxifylline in the rat. Pharmacol Res 47:331\u2013340","journal-title":"Pharmacol Res"},{"issue":"2","key":"993_CR2","first-page":"89","volume":"6","author":"ME Abdul Hadi","year":"2011","unstructured":"Abdul Hadi ME, Hisham A (2011) Pentoxifylline as a successful drug treatment for disseminated intravascular coagulopathy in Kassabach\u2013Merrit syndrome. Sudan Med Monit 6(2):89\u201391","journal-title":"Sudan Med Monit"},{"key":"993_CR3","doi-asserted-by":"publisher","first-page":"110012","DOI":"10.1016\/j.mehy.2020.110012","volume":"144","author":"MA Abouelkhair","year":"2020","unstructured":"Abouelkhair MA (2020) Targeting adenosinergic pathway and adenosine A2A receptor signaling for the treatment of COVID-19: a hypothesis. Med Hypotheses 144:110012","journal-title":"Med Hypotheses"},{"issue":"1","key":"993_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4103\/0973-6247.200768","volume":"11","author":"HM Al-Kuraishy","year":"2017","unstructured":"Al-Kuraishy HM, Al-Gareeb AI (2017) Comparison of deferasirox and deferoxamine effects on iron overload and immunological changes in patients with blood transfusion-dependent \u03b2-thalassemia. Asian J Transfus Sci 11(1):13","journal-title":"Asian J Transfus Sci"},{"key":"993_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43162-021-00064-x","volume":"33","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI (2021) Acute kidney injury and COVID-19. Egypt J Intern Med 33:1\u20135. https:\/\/doi.org\/10.1186\/s43162-021-00064-x","journal-title":"Egypt J Intern Med"},{"key":"993_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4103\/IJCIIS.IJCIIS_85_18","volume":"9","author":"HM Al-Kuraishy","year":"2019","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Hussien NR (2019) Synergistic effect of berberine and pentoxifylline in attenuation of acute kidney injury. Int J Crit Illn Inj Sci 9:69. https:\/\/doi.org\/10.4103\/IJCIIS.IJCIIS_85_18","journal-title":"Int J Crit Illn Inj Sci"},{"issue":"4","key":"993_CR7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.4103\/JMAU.JMAU_63_20","volume":"8","author":"HM Al-Kuraishy","year":"2020","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Al-Niemi MS, Al-Buhadily AK, Al-Harchan NA, Lugnier C (2020) COVID-19 and phosphodiesterase enzyme type 5 inhibitors. J Microsc Ultrastruct 8(4):141","journal-title":"J Microsc Ultrastruct"},{"key":"993_CR8","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1089\/vim.2021.0042","volume":"34","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Alkazmi L, Alexiou A, Batiha GE (2021a) Levamisole therapy in COVID-19. Viral Immunol 34:722\u2013725. https:\/\/doi.org\/10.1089\/vim.2021.0042","journal-title":"Viral Immunol"},{"key":"993_CR9","doi-asserted-by":"publisher","first-page":"174196","DOI":"10.1016\/j.ejphar.2021.174196","volume":"15","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Almulaiky YQ, Cruz-Martins N, Batiha GE (2021b) Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of Covid-19: the enigmatic entity. Eur J Pharmacol 15:174196","journal-title":"Eur J Pharmacol"},{"key":"993_CR10","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3389\/fphar642822","volume":"12","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Alqarni M, Cruz-Martins N, El-Saber Batiha G (2021c) Pleiotropic effects of tetracyclines in the management of COVID-19: emerging perspectives. Front Pharmacol 12:136. https:\/\/doi.org\/10.3389\/fphar642822","journal-title":"Front Pharmacol"},{"key":"993_CR11","doi-asserted-by":"publisher","first-page":"8195","DOI":"10.1007\/s11033-021-06770-7","volume":"48","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Alzahrani KJ, Alexiou A, Batiha GE (2021d) Niclosamide for Covid-19: bridging the gap. Mol Biol Rep 48:8195\u20138202. https:\/\/doi.org\/10.1007\/s11033-021-06770-7","journal-title":"Mol Biol Rep"},{"key":"993_CR12","doi-asserted-by":"publisher","first-page":"108516","DOI":"10.1016\/j.intimp.2021.108516","volume":"104","author":"HM Al-Kuraishy","year":"2022","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Al-Hussaniy HA, Al-Harcan NA, Alexiou A, Batiha GE (2022a) Neutrophil extracellular traps (NETs) and Covid-19: a new frontiers for therapeutic modality. Int Immunopharmacol 104:108516","journal-title":"Int Immunopharmacol"},{"key":"993_CR13","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.clnesp.2021.12.030","volume":"47","author":"HM Al-Kuraishy","year":"2022","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Batiha GE (2022b) The possible role of ursolic acid in Covid-19: a real game changer. Clin Nutr ESPEN 47:414\u2013417","journal-title":"Clin Nutr ESPEN"},{"key":"993_CR14","doi-asserted-by":"publisher","first-page":"109926","DOI":"10.1016\/j.mehy.2020.109926","volume":"143","author":"SF Assimakopoulos","year":"2020","unstructured":"Assimakopoulos SF, Seintis F, Marangos M (2020) Pentoxifylline and complicated COVID-19: a pathophysiologically based treatment proposal. Med Hypotheses 143:109926","journal-title":"Med Hypotheses"},{"issue":"4","key":"993_CR15","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s40618-014-0209-z","volume":"38","author":"A Azhar","year":"2015","unstructured":"Azhar A, El-Bassossy HM (2015) Pentoxifylline alleviates hypertension in metabolic syndrome: effect on low-grade inflammation and angiotensin system. J Endocrinol Investig 38(4):437\u2013445","journal-title":"J Endocrinol Investig"},{"key":"993_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13565","author":"S Bayraktar","year":"2021","unstructured":"Bayraktar S, Tanyeri-Bayraktar B (2021) Pentoxifylline in the treatment of neonatal vasospasm and thromboembolism: an observational case series study. J Clin Pharm Ther. https:\/\/doi.org\/10.1111\/jcpt.13565","journal-title":"J Clin Pharm Ther"},{"issue":"12","key":"993_CR18","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1097\/HJH.0000000000001086","volume":"34","author":"D Brie","year":"2016","unstructured":"Brie D, Sahebkar A, Penson PE, Dinca M, Ursoniu S, Serban MC, Zanchetti A, Howard G, Ahmed A, Aronow WS, Muntner P (2016) Effects of pentoxifylline on inflammatory markers and blood pressure: a systematic review and meta-analysis of randomized controlled trials. J Hypertens 34(12):2318\u20132329","journal-title":"J Hypertens"},{"issue":"16","key":"993_CR19","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1182\/blood-2017-03-745349","volume":"130","author":"JR Byrnes","year":"2017","unstructured":"Byrnes JR, Wolberg AS (2017) Red blood cells in thrombosis. Blood 130(16):1795\u20131799","journal-title":"Blood"},{"key":"993_CR20","doi-asserted-by":"publisher","first-page":"13030","DOI":"10.5070\/D3248041159","volume":"24","author":"N Chandan","year":"2018","unstructured":"Chandan N, Boen M, Lake EP, Aronson I (2018) Successful treatment of two individual cases of generalized granuloma annulare with amoxicillin\/clavulanic acid and a combination of doxycycline and pentoxifylline. Dermatol Online J 24:13030","journal-title":"Dermatol Online J"},{"key":"993_CR21","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.csbj.2021.02.009","volume":"19","author":"AP Chavarr\u00eda","year":"2021","unstructured":"Chavarr\u00eda AP, V\u00e1zquez RR, Cherit JG, Bello HH, Suastegui HC, Moreno-Casta\u00f1eda L, Estrada GA, Hern\u00e1ndez F, Gonz\u00e1lez-Marcos O, Saucedo-Orozco H, Manzano-Pech L (2021) Antioxidants and pentoxifylline as coadjuvant measures to standard therapy to improve prognosis of patients with pneumonia by COVID-19. Comput Struct Biotechnol J 19:1379\u20131390","journal-title":"Comput Struct Biotechnol J"},{"issue":"9","key":"993_CR22","doi-asserted-by":"publisher","first-page":"e12749","DOI":"10.1111\/and.12749","volume":"49","author":"S Chehrei","year":"2017","unstructured":"Chehrei S, Moradi M, Ghiabi HR, Falahi M, Kaviani S, Ghanbari A (2017) Pentoxifylline besides naltrexone recovers morphine-induced inflammation in male reproductive system of rats by regulating Toll-like receptor pathway. Andrologia 49(9):e12749","journal-title":"Andrologia"},{"issue":"4","key":"993_CR23","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1080\/154386090897974","volume":"5","author":"ME D\u00e1vila-Esqueda","year":"2004","unstructured":"D\u00e1vila-Esqueda ME, Martinez-Morales F (2004) Pentoxifylline diminishes the oxidative damage to renal tissue induced by streptozotocin in the rat. Exp Diabetes Res 5(4):245\u2013251","journal-title":"Exp Diabetes Res"},{"issue":"9","key":"993_CR24","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3390\/antiox9090897","volume":"9","author":"N de Las Heras","year":"2020","unstructured":"de Las Heras N, Mart\u00edn Gim\u00e9nez VM, Ferder L, Manucha W, Lahera V (2020) Implications of oxidative stress and potential role of mitochondrial dysfunction in COVID-19: therapeutic effects of vitamin D. Antioxidants 9(9):897","journal-title":"Antioxidants"},{"issue":"1","key":"993_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12950-014-0044-1","volume":"12","author":"FA de Oliveira Garcia","year":"2015","unstructured":"de Oliveira Garcia FA, Rebou\u00e7as JF, Balbino TQ, da Silva TG, de Carvalho-J\u00fanior CH, Cerqueira GS, de Castro Brito GA, de Barros Viana GS (2015) Pentoxifylline reduces the inflammatory process in diabetic rats: relationship with decreases of pro-inflammatory cytokines and inducible nitric oxide synthase. J Inflamm 12(1):1","journal-title":"J Inflamm"},{"key":"993_CR26","first-page":"S35","volume":"53","author":"MT De Sanctis","year":"2002","unstructured":"De Sanctis MT, Cesarone MR, Belcaro G, Incandela L (2002) Treatment of retinal vein thrombosis with pentoxifylline: a controlled, randomized trial. Angiology 53:S35","journal-title":"Angiology"},{"issue":"1","key":"993_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12038-020-00053-2","volume":"45","author":"B Deb","year":"2020","unstructured":"Deb B, Shah H, Goel S (2020) Current global vaccine and drug efforts against COVID-19: pros and cons of bypassing animal trials. J Biosci 45(1):1","journal-title":"J Biosci"},{"key":"993_CR28","doi-asserted-by":"publisher","first-page":"8570","DOI":"10.1200\/JCO.2005.02.4729","volume":"23","author":"S Delanian","year":"2005","unstructured":"Delanian S, Porcher R, Rudant J, Lefaix JL (2005) Kinetics of response to long-term treatment combining pentoxifylline and tocopherol in patients with superficial radiation-induced fibrosis. J Clin Oncol 23:8570\u20138579","journal-title":"J Clin Oncol"},{"issue":"5","key":"993_CR29","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.arcmed.2020.04.019","volume":"51","author":"L Delgado-Roche","year":"2020","unstructured":"Delgado-Roche L, Mesta F (2020) Oxidative stress as key player in severe acute respiratory syndrome coronavirus (SARS-CoV) infection. Arch Med Res 51(5):384\u2013387","journal-title":"Arch Med Res"},{"key":"993_CR30","doi-asserted-by":"publisher","first-page":"125762","DOI":"10.1016\/j.jhazmat.2021.125762","volume":"416","author":"GC Dianey","year":"2021","unstructured":"Dianey GC, Kaur H, Dosanjh HS, Narayanan J, Singh J, Yadav A, Kumar D, Luu SD, Sharma A, Singh PP, Alberto HA (2021) Sunlight powered degradation of pentoxifylline Cs0.5Li0.5FeO2 as a green reusable photocatalyst: Mechanism, kinetics and toxicity studies. J Hazard Mater 416:125762","journal-title":"J Hazard Mater"},{"key":"993_CR31","first-page":"1141","volume":"17","author":"J Dong","year":"2018","unstructured":"Dong J, Yuan X, Xie W (2018) Pentoxifylline exerts anti-inflammatory effects on cerebral ischemia reperfusion-induced injury in a rat model via the p38 mitogen-activated protein kinase signaling pathway. Mol Med Rep 17:1141\u20131147","journal-title":"Mol Med Rep"},{"issue":"3","key":"993_CR32","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3390\/cells9030785","volume":"9","author":"WI Effendi","year":"2020","unstructured":"Effendi WI, Nagano T, Kobayashi K, Nishimura Y (2020) Focusing on adenosine receptors as a potential targeted therapy in human diseases. Cells 9(3):785","journal-title":"Cells"},{"key":"993_CR33","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.atherosclerosis.2006.11.032","volume":"196","author":"JL Fernandes","year":"2008","unstructured":"Fernandes JL, de Oliveira RT, Mamoni RL, Coelho OR, Nicolau JC, Blotta MH, Serrano CV Jr (2008) Pentoxifylline reduces pro-inflammatory and increases anti-inflammatory activity in patients with coronary artery disease\u2014a randomized placebo-controlled study. Atherosclerosis 196:434\u2013442","journal-title":"Atherosclerosis"},{"key":"993_CR34","doi-asserted-by":"publisher","first-page":"480","DOI":"10.2165\/00002512-199507060-00007","volume":"7","author":"JE Frampton","year":"1995","unstructured":"Frampton JE, Brogden RN (1995) Pentoxifylline (oxpentifylline). Drugs Aging 7:480\u2013503. https:\/\/doi.org\/10.2165\/00002512-199507060-00007","journal-title":"Drugs Aging"},{"key":"993_CR16","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.3389\/fimmu.2020.01518","volume":"11","author":"TL Freeman","year":"2020","unstructured":"Freeman TL, Swartz TH (2020) Targeting the NLRP3 inflammasome in severe COVID-19. Front Immunol. 11:1518","journal-title":"Front Immunol."},{"issue":"1","key":"993_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2193-1801-3-283","volume":"3","author":"FA Garcia","year":"2014","unstructured":"Garcia FA, Pinto SF, Cavalcante AF, Lucetti LT, Menezes SM, Felipe CF, Alves AP, Brito GA, Cerqueira GS, Viana GS (2014) Pentoxifylline decreases glycemia levels and TNF-alpha, iNOS and COX-2 expressions in diabetic rat pancreas. Springerplus 3(1):1\u20131","journal-title":"Springerplus"},{"issue":"3","key":"993_CR36","doi-asserted-by":"publisher","first-page":"100742","DOI":"10.1016\/j.cpcardiol.2020.100742","volume":"46","author":"JE Gomez-Mesa","year":"2021","unstructured":"Gomez-Mesa JE, Galindo-Coral S, Montes MC, Martin AJ (2021) Thrombosis and coagulopathy in COVID-19. Curr Probl Cardiol 46(3):100742","journal-title":"Curr Probl Cardiol"},{"key":"993_CR37","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4049\/jimmunol.161.1.65","volume":"161","author":"R Gonz\u00e1lez-Amaro","year":"1998","unstructured":"Gonz\u00e1lez-Amaro R, Portales-P\u00e9rez D, Baranda L, Redondo JM, Mart\u00ednez-Mart\u00ednez S, Y\u00e1\u00f1ez-M\u00f3 M, Garc\u00eda-Vicu\u00f1a R, Caba\u00f1as C, S\u00e1nchez-Madrid F (1998) Pentoxifylline inhibits adhesion and activation of human T lymphocytes. J Immunol 161:65\u201372","journal-title":"J Immunol"},{"issue":"7","key":"993_CR38","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.ejheart.2008.05.004","volume":"10","author":"A Guggilam","year":"2008","unstructured":"Guggilam A, Patel KP, Haque M, Ebenezer PJ, Kapusta DR, Francis J (2008) Cytokine blockade attenuates sympathoexcitation in heart failure: cross-talk between nNOS, AT-1R and cytokines in the hypothalamic paraventricular nucleus. Eur J Heart Fail 10(7):625\u2013634","journal-title":"Eur J Heart Fail"},{"key":"993_CR39","doi-asserted-by":"publisher","first-page":"115184","DOI":"10.1016\/j.taap.2020.115184","volume":"404","author":"M Hekmat","year":"2020","unstructured":"Hekmat M, Schaalan MF, Rahmo RM, Farag DB, Khedr LH (2020) Implications of miRNAs on TGF-\u03b2\/TAK1\/mTOR pathway in mediating the renoprotective effects of pentoxifylline against cisplatin-induced nephrotoxicity in rats. Toxicol Appl Pharmacol 404:115184","journal-title":"Toxicol Appl Pharmacol"},{"issue":"4","key":"993_CR40","doi-asserted-by":"publisher","first-page":"e00631","DOI":"10.1002\/prp2.631","volume":"8","author":"BM Hendry","year":"2020","unstructured":"Hendry BM, Stafford N, Arnold AD, Sangwaiya A, Manglam V, Rosen SD, Arnold J (2020a) Hypothesis: pentoxifylline is a potential cytokine modulator therapeutic in COVID-19 patients. Pharmacol Res Perspect 8(4):e00631","journal-title":"Pharmacol Res Perspect"},{"issue":"3","key":"993_CR41","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s10620-009-0780-x","volume":"55","author":"G Hepg\u00fcl","year":"2010","unstructured":"Hepg\u00fcl G, Tanr\u0131kulu S, \u00dcnalp HR, Akguner T, Erbil Y, Olga\u00e7 V, Ademo\u011flu E (2010) Preventive effect of pentoxifylline on acute radiation damage via antioxidant and anti-inflammatory pathways. Dig Dis Sci 55(3):617\u2013625","journal-title":"Dig Dis Sci"},{"issue":"1","key":"993_CR42","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/00002826-200201000-00007","volume":"25","author":"B Horvath","year":"2002","unstructured":"Horvath B, Marton Z, Halmosi R, Alexy T, Szapary L, Vekasi J, Biro Z, Habon T, Kesmarky G, Toth K (2002) In vitro antioxidant properties of pentoxifylline, piracetam, and vinpocetine. Clin Neuropharmacol 25(1):37\u201342","journal-title":"Clin Neuropharmacol"},{"key":"993_CR43","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4103\/jrms.JRMS_115_18","volume":"24","author":"F Hosseini","year":"2019","unstructured":"Hosseini F, Mohammadbeigi A, Aghaali M, Borujerdi R, Parham M (2019) Effect of pentoxifylline on diabetic distal polyneuropathy in type 2 diabetic patients: a randomized trial. J Res Med Sci 24:89","journal-title":"J Res Med Sci"},{"issue":"8","key":"993_CR44","first-page":"93","volume":"69","author":"NR Hussien","year":"2019","unstructured":"Hussien NR, Al-Kuraishy HM, Al-Gareeb AI (2019) Berberine and pentoxifylline: a novel combination in amelioration of acute kidney injury. J Pak Med Assoc 69(8):93\u201397","journal-title":"J Pak Med Assoc"},{"key":"993_CR45","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.esxm.2019.07.003","volume":"7","author":"A Ibrahim","year":"2019","unstructured":"Ibrahim A, Gazzard L, Alharbi M, Rompr\u00e9-Brodeur A, Aube M, Carrier S (2019) Evaluation of oral pentoxifylline, colchicine, and penile traction for the management of Peyronie\u2019s disease. Sex Med 7:459\u2013463","journal-title":"Sex Med"},{"issue":"3","key":"993_CR46","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s12262-013-1025-y","volume":"77","author":"M Jafari-Sabet","year":"2015","unstructured":"Jafari-Sabet M, Shishegar A, Saeedi AR, Ghahari S (2015) Pentoxifylline increases antiadhesion effect of streptokinase on postoperative adhesion formation: involvement of Fibrinolytic pathway. Indian J Surg 77(3):837\u2013842","journal-title":"Indian J Surg"},{"issue":"4","key":"993_CR47","first-page":"427","volume":"34","author":"Q Ji","year":"2004","unstructured":"Ji Q, Zhang L, Jia H, Yang J, Xu J (2004) Pentoxifylline inhibits endotoxin-induced NF-kappa B activation and associated production of proinflammatory cytokines. Ann Clin Lab Sci 34(4):427\u2013436","journal-title":"Ann Clin Lab Sci"},{"issue":"4","key":"993_CR48","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1002\/jmv.26728","volume":"93","author":"BS Karam","year":"2021","unstructured":"Karam BS, Morris RS, Bramante CT, Puskarich M, Zolfaghari EJ, Lotfi-Emran S, Ingraham NE, Charles A, Odde DJ, Tignanelli CJ (2021) mTOR inhibition in COVID-19: a commentary and review of efficacy in RNA viruses. J Med Virol 93(4):1843\u20131846","journal-title":"J Med Virol"},{"issue":"1","key":"993_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-018-0763-3","volume":"17","author":"R Kaur","year":"2018","unstructured":"Kaur R, Kaur M, Singh J (2018) Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies. Cardiovasc Diabetol 17(1):1\u20137","journal-title":"Cardiovasc Diabetol"},{"key":"993_CR50","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ijom.2018.08.007","volume":"48","author":"A Kolokythas","year":"2019","unstructured":"Kolokythas A, Rasmussen JT, Reardon J, Feng C (2019) Management of osteoradionecrosis of the jaws with pentoxifylline\u2013tocopherol: a systematic review of the literature and meta-analysis. Int J Oral Maxillofac Surg 48:173\u2013180","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"14","key":"993_CR51","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1016\/j.bpj.2021.05.025","volume":"120","author":"M Kub\u00e1nkov\u00e1","year":"2021","unstructured":"Kub\u00e1nkov\u00e1 M, Hohberger B, Hoffmanns J, F\u00fcrst J, Herrmann M, Guck J, Kr\u00e4ter M (2021) Physical phenotype of blood cells is altered in COVID-19. Biophys J 120(14):2838\u20132847","journal-title":"Biophys J"},{"issue":"6494","key":"993_CR52","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1126\/science.abc6141","volume":"368","author":"SS Lakdawala","year":"2020","unstructured":"Lakdawala SS, Menachery VD (2020) The search for a COVID-19 animal model. Science 368(6494):942\u2013943","journal-title":"Science"},{"key":"993_CR53","doi-asserted-by":"publisher","first-page":"176","DOI":"10.5152\/iao.2018.4690","volume":"14","author":"WC Lan","year":"2018","unstructured":"Lan WC, Wang CY, Lin CD (2018) Pentoxifylline versus steroid therapy for idiopathic sudden sensorineural hearing loss with diabetes. J Int Adv Otol 14:176","journal-title":"J Int Adv Otol"},{"key":"993_CR54","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.esxm.2019.08.012","volume":"8","author":"YX Law","year":"2020","unstructured":"Law YX, Tai BC, Tan YQ, Lata RN, Lee KC (2020) A small group randomized double-blind placebo-controlled study to evaluate the efficacy of daily pentoxifylline in the management of patients with erectile dysfunction with suboptimal treatment response to sildenafil. Sex Med 8:14\u201320","journal-title":"Sex Med"},{"issue":"1","key":"993_CR55","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1172\/JCI116934","volume":"93","author":"M Levi","year":"1994","unstructured":"Levi M, ten Cate H, Bauer KA, van der Poll T, Edgington TS, B\u00fcller HR, Van Deventer SJ, Hack CE, ten Cate JW, Rosenberg RD (1994) Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Investig 93(1):114\u2013120","journal-title":"J Clin Investig"},{"issue":"3","key":"993_CR56","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1001\/jama.2020.25864","volume":"325","author":"RD Lopes","year":"2021","unstructured":"Lopes RD, Macedo AV, Silva PG, Moll-Bernardes RJ, Dos Santos TM, Mazza L, Feldman A, Arruda GD, Den\u00edlson C, Camiletti AS, Sousa De (2021) AS effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19: a randomized clinical trial. JAMA 325(3):254\u2013264","journal-title":"JAMA"},{"key":"993_CR57","doi-asserted-by":"publisher","first-page":"107209","DOI":"10.1016\/j.intimp.2020.107209","volume":"90","author":"V Maldonado","year":"2021","unstructured":"Maldonado V, Hernandez-Ram\u00edrez C, Oliva-P\u00e9rez EA, S\u00e1nchez-Mart\u00ednez CO, Pimentel-Gonz\u00e1lez JF, Molina-S\u00e1nchez JR, Jim\u00e9nez-Villalba YZ, Ch\u00e1vez-Alderete J, Loza-Mej\u00eda MA (2021) Pentoxifylline decreases serum LDH levels and increases lymphocyte count in COVID-19 patients: results from an external pilot study. Int Immunopharmacol 90:107209","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"993_CR58","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0162-3109(00)00249-6","volume":"49","author":"J Marcinkiewicz","year":"2000","unstructured":"Marcinkiewicz J, Grabowska A, Lauterbach R, Bobek M (2000) Differential effects of pentoxifylline, a non-specific phosphodiesterase inhibitor, on the production of IL-10, IL-12 p40 and p35 subunits by murine peritoneal macrophages. Immunopharmacology 49(3):335\u2013343","journal-title":"Immunopharmacology"},{"key":"993_CR59","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1164\/ajrccm.159.2.9804085","volume":"159","author":"LJ Marques","year":"1999","unstructured":"Marques LJ, Zheng L, Poulakis N, Guzman J, Costabel U (1999) Pentoxifylline inhibits TNF-\u03b1 production from human alveolar macrophages. Am J Respir Crit Care Med 159:508\u2013511","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"993_CR60","doi-asserted-by":"publisher","first-page":"666","DOI":"10.3109\/10641963.2015.1047944","volume":"37","author":"F Mayyas","year":"2015","unstructured":"Mayyas F, Alzoubi KH, Al-Taleb Z (2015) An evaluation of the effect of pentoxifylline on blood pressure and myocardial oxidative status following intake of western diet. Clin Exp Hypertens 37(8):666\u2013673","journal-title":"Clin Exp Hypertens"},{"issue":"1","key":"993_CR61","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/S0022-4804(03)00219-1","volume":"115","author":"C Michetti","year":"2003","unstructured":"Michetti C, Coimbra R, Hoyt DB, Loomis W, Junger W, Wolf P (2003) Pentoxifylline reduces acute lung injury in chronic endotoxemia. J Surg Res 115(1):92\u201399","journal-title":"J Surg Res"},{"issue":"7","key":"993_CR62","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1089\/ars.2012.5149","volume":"20","author":"M Mittal","year":"2014","unstructured":"Mittal M, Siddiqui MR, Tran K, Reddy SP, Malik AB (2014) Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal 20(7):1126\u20131167","journal-title":"Antioxid Redox Signal"},{"key":"993_CR63","doi-asserted-by":"publisher","first-page":"173561","DOI":"10.1016\/j.ejphar.2020.173561","volume":"887","author":"F Monji","year":"2020","unstructured":"Monji F, Siddiquee AA, Hashemian F (2020) Can pentoxifylline and similar xanthine derivatives find a niche in COVID-19 therapeutic strategies? A ray of hope in the midst of the pandemic. Eur J Pharmacol 887:173561","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"993_CR64","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1078\/0171-2985-00108","volume":"205","author":"MJ Myers","year":"2002","unstructured":"Myers MJ, Baarsch MJ, Murtaugh MP (2002) Effects of pentoxifylline on inflammatory cytokine expression and acute pleuropneumonia in swine. Immunobiology 205(1):17\u201334","journal-title":"Immunobiology"},{"issue":"3","key":"993_CR65","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/ajh.26440","volume":"97","author":"E Nader","year":"2021","unstructured":"Nader E, Nougier C, Boisson C, Poutrel S, Catella J, Martin F, Charvet J, Girard S, Havard-Guibert S, Martin M, Rezigue H (2021) Increased blood viscosity and red blood cell aggregation in patients with COVID-19. Am J Hematol 97(3):283\u2013292","journal-title":"Am J Hematol"},{"issue":"7","key":"993_CR66","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1681\/ASN.2005010001","volume":"16","author":"JF Navarro","year":"2005","unstructured":"Navarro JF, Mora C, Muros M, Garc\u00eda J (2005) Additive antiproteinuric effect of pentoxifylline in patients with type 2 diabetes under angiotensin II receptor blockade: a short-term, randomized, controlled trial. J Am Soc Nephrol 16(7):2119\u20132126","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"993_CR67","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1159\/000098004","volume":"26","author":"JF Navarro","year":"2006","unstructured":"Navarro JF, Milena FJ, Mora C, Le\u00f3n C, Garc\u00eda J (2006) Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: effect of angiotensin-converting enzyme inhibition and pentoxifylline administration. Am J Nephrol 26(6):562\u2013570","journal-title":"Am J Nephrol"},{"issue":"1","key":"993_CR68","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/cbf.991","volume":"21","author":"T Noyan","year":"2003","unstructured":"Noyan T, \u00d6nem \u00d6, Ramazan \u015eekero\u011flu M, K\u00f6seo\u011flu B, D\u00fclger H, Bayram \u0130, Sad\u0131k Yal\u00e7inkaya A, Bakan V (2003) Effects of erythropoietin and pentoxifylline on the oxidant and antioxidant systems in the experimental short bowel syndrome. Cell Biochem Funct 21(1):49\u201354","journal-title":"Cell Biochem Funct"},{"issue":"4","key":"993_CR69","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/j.fertnstert.2008.09.024","volume":"91","author":"A Oliva","year":"2009","unstructured":"Oliva A, Dotta A, Multigner L (2009) Pentoxifylline and antioxidants improve sperm quality in male patients with varicocele. Fertil Steril 91(4):1536\u20131539","journal-title":"Fertil Steril"},{"issue":"11","key":"993_CR70","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1590\/S0100-879X2006001100009","volume":"39","author":"IS Oliveira-J\u00fanior","year":"2006","unstructured":"Oliveira-J\u00fanior IS, Brunialti MK, Koh IH, Junqueira VB, Salom\u00e3o R (2006) Effect of pentoxifylline on lung inflammation and gas exchange in a sepsis-induced acute lung injury model. Braz J Med Biol Res 39(11):1455\u20131463","journal-title":"Braz J Med Biol Res"},{"key":"993_CR71","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1007\/s00210-021-02147-6","volume":"394","author":"H Onohuean","year":"2021","unstructured":"Onohuean H, Al-Kuraishy HM, Al-Gareeb AI, Qusti S, Alshammari EM, Batiha GE (2021) Covid-19 and development of heart failure: mystery and truth. Naunyn Schmiedebergs Arch Pharmacol 394:2013\u20132021","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"3","key":"993_CR72","first-page":"233","volume":"34","author":"MG Ozden","year":"2019","unstructured":"Ozden MG, Koksal G, Oz H (2019) Comparison of antithrombin iii and pentoxifylline treatments in gram negative sepsis patients developing disseminated intravascular coagulation. Medeni Med J 34(3):233","journal-title":"Medeni Med J"},{"issue":"5","key":"993_CR73","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00240-018-1072-8","volume":"47","author":"H Ozturk","year":"2019","unstructured":"Ozturk H, Cetinkaya A, Firat TS, Tekce BK, Duzcu SE, Ozturk H (2019) Protective effect of pentoxifylline on oxidative renal cell injury associated with renal crystal formation in a hyperoxaluric rat model. Urolithiasis 47(5):415\u2013424","journal-title":"Urolithiasis"},{"key":"993_CR74","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-131764\/v1","author":"SJ Park","year":"2020","unstructured":"Park SJ, Choi SH, Cho YD, Kim JY, Cho HJ, Lim CS, Kim KH, Kim WY (2020) Pentoxifylline restores T Cell viability in hyper-inflammatory conditions. Res Sq. https:\/\/doi.org\/10.21203\/rs.3.rs-131764\/v1","journal-title":"Res Sq"},{"issue":"2","key":"993_CR75","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1378\/chest.127.2.613","volume":"127","author":"MT Pawlik","year":"2005","unstructured":"Pawlik MT, Schreyer AG, Ittner KP, Selig C, Gruber M, Feuerbach S, Taeger K (2005) Early treatment with pentoxifylline reduces lung injury induced by acid aspiration in rats. Chest 127(2):613\u2013621","journal-title":"Chest"},{"key":"993_CR76","doi-asserted-by":"publisher","first-page":"102468","DOI":"10.1016\/j.jaut.2020.102468","volume":"111","author":"C Perricone","year":"2020","unstructured":"Perricone C, Triggianese P, Bartoloni E, Cafaro G, Bonifacio AF, Bursi R, Perricone R, Gerli R (2020) The anti-viral facet of anti-rheumatic drugs: lessons from COVID-19. J Autoimmun 111:102468","journal-title":"J Autoimmun"},{"issue":"2","key":"993_CR77","doi-asserted-by":"publisher","first-page":"589","DOI":"10.4049\/jimmunol.174.2.589","volume":"174","author":"M Peters-Golden","year":"2005","unstructured":"Peters-Golden M, Canetti C, Mancuso P, Coffey MJ (2005) Leukotrienes: underappreciated mediators of innate immune responses. J Immunol 174(2):589\u2013594","journal-title":"J Immunol"},{"key":"993_CR78","doi-asserted-by":"publisher","first-page":"307","DOI":"10.22159\/ijap.2018.v10s1.68","volume":"10","author":"A Rasyid","year":"2018","unstructured":"Rasyid A, Harris S, Nurhayati E, Prihartono J (2018) Pentoxifylline in acute ischemic stroke patients with blood hyperviscosity. Int J Appl Pharm 10:307\u2013310","journal-title":"Int J Appl Pharm"},{"issue":"10","key":"993_CR79","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1111\/j.1572-0241.2004.40220.x","volume":"99","author":"SK Satapathy","year":"2004","unstructured":"Satapathy SK, Garg S, Chauhan R, Sakhuja P, Malhotra V, Sharma BC, Sarin SK (2004) Beneficial effects of tumor necrosis factor-\u03b1 inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis. Am J Gastroenterol 99(10):1946\u20131952","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"993_CR80","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ijantimicag.2008.07.013","volume":"33","author":"L Sebastian","year":"2009","unstructured":"Sebastian L, Desai A, Madhusudana SN, Ravi V (2009) Pentoxifylline inhibits replication of Japanese encephalitis virus: a comparative study with ribavirin. Int J Antimicrob Agents 33(2):168\u2013173","journal-title":"Int J Antimicrob Agents"},{"key":"993_CR81","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ajem.2020.11.058","volume":"40","author":"M Seyit","year":"2021","unstructured":"Seyit M, Avci E, Nar R, Senol H, Yilmaz A, Ozen M, Oskay A, Aybek H (2021) Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19. Am J Emerg Med 40:110\u2013114","journal-title":"Am J Emerg Med"},{"key":"993_CR82","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.3389\/fimmu.2020.01472","volume":"11","author":"A Sfera","year":"2020","unstructured":"Sfera A, Osorio C, Jafri N, Diaz EL, Campo Maldonado JE (2020) Intoxication with endogenous angiotensin II: a COVID-19 hypothesis. Front Immunol 11:1472","journal-title":"Front Immunol"},{"key":"993_CR83","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fphys.2018.00114","volume":"9","author":"A Sharma","year":"2018","unstructured":"Sharma A, Tate M, Mathew G, Vince JE, Ritchie RH, De Haan JB (2018) Oxidative stress and NLRP3-inflammasome activity as significant drivers of diabetic cardiovascular complications: therapeutic implications. Front Physiol 9:114","journal-title":"Front Physiol"},{"issue":"4","key":"993_CR84","doi-asserted-by":"publisher","first-page":"324","DOI":"10.2174\/1570164617666190906151348","volume":"17","author":"X Shi","year":"2020","unstructured":"Shi X, Appiah-Kubi K (2020) Platelet-derived growth factors (PDGFs) are key players in the stimulation of airway smooth muscle cells (ASMCs) alteration in asthma and chronic obstructive pulmonary disease (COPD) with multifarious inhibitors at an early stage of development. Curr Proteom 17(4):324\u2013332","journal-title":"Curr Proteom"},{"issue":"5","key":"993_CR85","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1159\/000109752","volume":"50","author":"JA Smith","year":"2007","unstructured":"Smith JA, Nunnari G, Preuss M, Pomerantz RJ, Daniel R (2007) Pentoxifylline suppresses transduction by HIV-1-based vectors. Intervirology 50(5):377\u2013386","journal-title":"Intervirology"},{"issue":"2","key":"993_CR86","doi-asserted-by":"publisher","first-page":"E70","DOI":"10.1148\/radiol.2020203557","volume":"298","author":"YJ Suh","year":"2021","unstructured":"Suh YJ, Hong H, Ohana M, Bompard F, Revel MP, Valle C, Gervaise A, Poissy J, Susen S, H\u00e9kimian G, Artifoni M (2021) Pulmonary embolism and deep vein thrombosis in COVID-19: a systematic review and meta-analysis. Radiology 298(2):E70-80","journal-title":"Radiology"},{"issue":"1","key":"993_CR87","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.yexmp.2014.05.009","volume":"97","author":"VR Sunil","year":"2014","unstructured":"Sunil VR, Vayas KN, Cervelli JA, Malaviya R, Hall L, Massa CB, Gow AJ, Laskin JD, Laskin DL (2014) Pentoxifylline attenuates nitrogen mustard-induced acute lung injury, oxidative stress and inflammation. Exp Mol Pathol 97(1):89\u201398","journal-title":"Exp Mol Pathol"},{"key":"993_CR88","first-page":"190","volume":"03","author":"X Tao","year":"2001","unstructured":"Tao X, Peng Y, Yang Y (2001) Effect of pentoxifylline on the expression level of TNF-\u03b1 induced by respiratory syncytial virus-infected human alveolar macrophages. J Clin Intern Med 03:190\u2013191","journal-title":"J Clin Intern Med"},{"issue":"12","key":"993_CR89","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1161\/ATVBAHA.120.315175","volume":"40","author":"F Taus","year":"2020","unstructured":"Taus F, Salvagno G, Can\u00e8 S, Fava C, Mazzaferri F, Carrara E, Petrova V, Barouni RM, Dima F, Dalbeni A, Romano S (2020) Platelets promote thromboinflammation in SARS-CoV-2 pneumonia. Arterioscler Thromb Vasc Biol 40(12):2975\u20132989","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"993_CR90","first-page":"97","volume":"7","author":"TV Timchenko","year":"2019","unstructured":"Timchenko TV, Pogorely VE, Voronkov AV, Markova OM, Shcherbakova LI, Kompantsev VA, Medvetsky AI, Platonova AY (2019) Experimental study of anti-thrombotic activity of pentoxyfillin microparticles: based on poly-dl-lactide-co-glycolide in comparison with pentoxyfillin. \u0424ap\u043ca\u0446\u0438\u044f \u0438 \u0424ap\u043ca\u043ao\u043bo\u0433\u0438\u044f 7(2):97\u2013104","journal-title":"\u0424ap\u043ca\u0446\u0438\u044f \u0438 \u0424ap\u043ca\u043ao\u043bo\u0433\u0438\u044f"},{"key":"993_CR91","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1378\/chest.124.4.1526","volume":"124","author":"Z Tong","year":"2003","unstructured":"Tong Z, Dai H, Chen B, Abdoh Z, Guzman J, Costabel U (2003) Inhibition of cytokine release from alveolar macrophages in pulmonary sarcoidosis by pentoxifylline: comparison with dexamethasone. Chest 124:1526\u20131532","journal-title":"Chest"},{"issue":"7","key":"993_CR92","doi-asserted-by":"publisher","first-page":"e00127","DOI":"10.1128\/JVI.00127-20","volume":"94","author":"Y Wan","year":"2020","unstructured":"Wan Y, Shang J, Graham R, Baric RS, Li F (2020) Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol 94(7):e00127-e220","journal-title":"J Virol"},{"issue":"1","key":"993_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-017-0401-5","volume":"24","author":"LC Wang","year":"2017","unstructured":"Wang LC, Yao HW, Chang CF, Wang SW, Wang SM, Chen SH (2017) Suppression of interleukin-6 increases enterovirus A71 lethality in mice. J Biomed Sci 24(1):1\u20139","journal-title":"J Biomed Sci"},{"issue":"4","key":"993_CR94","doi-asserted-by":"publisher","first-page":"CD007339","DOI":"10.1002\/14651858.CD007339","volume":"2009","author":"K Whitfield","year":"2009","unstructured":"Whitfield K, Rambaldi A, Wetterslev J, Gluud C (2009) Pentoxifylline for alcoholic hepatitis. Cochrane Database Syst Rev 2009(4):CD007339. https:\/\/doi.org\/10.1002\/14651858.CD007339","journal-title":"Cochrane Database Syst Rev"},{"key":"993_CR95","unstructured":"Wikipedia (2014) Pentoxifylline. http:\/\/en.wikipedia.org\/wiki\/Pentoxifylline. Accessed 1 Mar 2022"},{"issue":"6","key":"993_CR96","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/RLI.0000000000000674","volume":"55","author":"Y Xiong","year":"2020","unstructured":"Xiong Y, Sun D, Liu Y, Fan Y, Zhao L, Li X, Zhu W (2020) Clinical and high-resolution CT features of the COVID-19 infection: comparison of the initial and follow-up changes. Investig Radiol 55(6):332\u2013339","journal-title":"Investig Radiol"},{"issue":"2","key":"993_CR97","first-page":"103","volume":"9","author":"M Zhang","year":"2004","unstructured":"Zhang M, Xu YJ, Mengi SA, Arneja AS, Dhalla NS (2004) Therapeutic potentials of pentoxifylline for treatment of cardiovascular diseases. Exp Clin Cardiol 9(2):103","journal-title":"Exp Clin Cardiol"},{"issue":"1","key":"993_CR98","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/FJC.0000000000000316","volume":"67","author":"X Zhang","year":"2016","unstructured":"Zhang X, Meng F, Song J, Zhang L, Wang J, Li D, Li L, Dong P, Yang B, Chen Y (2016) Pentoxifylline ameliorates cardiac fibrosis, pathological hypertrophy, and cardiac dysfunction in angiotensin II-induced hypertensive rats. J Cardiovasc Pharmacol 67(1):76\u201385","journal-title":"J Cardiovasc Pharmacol"},{"issue":"8","key":"993_CR99","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.7150\/ijbs.34211","volume":"15","author":"W Zhao","year":"2019","unstructured":"Zhao W, Ma L, Cai C, Gong X (2019) Caffeine inhibits NLRP3 inflammasome activation by suppressing MAPK\/NF-\u03baB and A2aR signaling in LPS-Induced THP-1 macrophages. Int J Biol Sci 15(8):1571","journal-title":"Int J Biol Sci"},{"issue":"7843","key":"993_CR100","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41586-020-2943-z","volume":"589","author":"J Zheng","year":"2021","unstructured":"Zheng J, Wong LY, Li K, Verma AK, Ortiz ME, Wohlford-Lenane C, Leidinger MR, Knudson CM, Meyerholz DK, McCray PB, Perlman S (2021) COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice. Nature 589(7843):603\u2013607","journal-title":"Nature"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-022-00993-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-022-00993-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-022-00993-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T00:13:18Z","timestamp":1675469598000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-022-00993-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,29]]},"references-count":100,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["993"],"URL":"https:\/\/doi.org\/10.1007\/s10787-022-00993-1","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,29]]},"assertion":[{"value":"19 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}